Thus, genomic instability (i.e., splicing alterations, somatic mutations, gene fusions) appears to contribute to persistent DDR and p53 signaling in ALS, especially in those with TDP-43 proteinopathy. The gene discussed is TP53; the disease is amyotrophic lateral sclerosis.